228 related articles for article (PubMed ID: 37021641)
1. Addressing the gaps in homeostatic mechanisms of copper and copper dithiocarbamate complexes in cancer therapy: a shift from classical platinum-drug mechanisms.
Njenga LW; Mbugua SN; Odhiambo RA; Onani MO
Dalton Trans; 2023 May; 52(18):5823-5847. PubMed ID: 37021641
[TBL] [Abstract][Full Text] [Related]
2. Targeting copper in cancer therapy: 'Copper That Cancer'.
Denoyer D; Masaldan S; La Fontaine S; Cater MA
Metallomics; 2015 Nov; 7(11):1459-76. PubMed ID: 26313539
[TBL] [Abstract][Full Text] [Related]
3. Metallo-Drugs in Cancer Therapy: Past, Present and Future.
Lucaciu RL; Hangan AC; Sevastre B; Oprean LS
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235023
[TBL] [Abstract][Full Text] [Related]
4. Anticancer metallodrugs: where is the next cisplatin?
Hanif M; Hartinger CG
Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
[TBL] [Abstract][Full Text] [Related]
5. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
Lazarević T; Rilak A; Bugarčić ŽD
Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
[TBL] [Abstract][Full Text] [Related]
6. Noble metal-dithiocarbamates precious allies in the fight against cancer.
Nagy EM; Ronconi L; Nardon C; Fregona D
Mini Rev Med Chem; 2012 Oct; 12(12):1216-29. PubMed ID: 22931593
[TBL] [Abstract][Full Text] [Related]
7. Novel metals and metal complexes as platforms for cancer therapy.
Frezza M; Hindo S; Chen D; Davenport A; Schmitt S; Tomco D; Dou QP
Curr Pharm Des; 2010 Jun; 16(16):1813-25. PubMed ID: 20337575
[TBL] [Abstract][Full Text] [Related]
8. A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies.
Adhikari S; Nath P; Das A; Datta A; Baildya N; Duttaroy AK; Pathak S
Biomed Pharmacother; 2024 Feb; 171():116211. PubMed ID: 38290253
[TBL] [Abstract][Full Text] [Related]
9. Copper, gold and silver compounds as potential new anti-tumor metallodrugs.
Tan SJ; Yan YK; Lee PP; Lim KH
Future Med Chem; 2010 Oct; 2(10):1591-608. PubMed ID: 21426151
[TBL] [Abstract][Full Text] [Related]
10. Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review.
Abdolmaleki S; Aliabadi A; Khaksar S
J Cancer Res Clin Oncol; 2024 Apr; 150(4):213. PubMed ID: 38662225
[TBL] [Abstract][Full Text] [Related]
11. New applications of old metal-binding drugs in the treatment of human cancer.
Schmitt SM; Frezza M; Dou QP
Front Biosci (Schol Ed); 2012 Jan; 4(1):375-91. PubMed ID: 22202066
[TBL] [Abstract][Full Text] [Related]
12. Recent Progresses in Conjugation with Bioactive Ligands to Improve the Anticancer Activity of Platinum Compounds.
Zuccolo M; Arrighetti N; Perego P; Colombo D
Curr Med Chem; 2022; 29(15):2566-2601. PubMed ID: 34365939
[TBL] [Abstract][Full Text] [Related]
13. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
Zhang Z; Wang H; Yan M; Wang H; Zhang C
Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
[TBL] [Abstract][Full Text] [Related]
14. The Challenging Treatment of Cisplatin-Resistant Tumors: State of the Art and Future Perspectives.
Coffetti G; Moraschi M; Facchetti G; Rimoldi I
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110640
[TBL] [Abstract][Full Text] [Related]
15. Fresh platinum complexes with promising antitumor activity.
Wang X
Anticancer Agents Med Chem; 2010 Jun; 10(5):396-411. PubMed ID: 20545618
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
17. Metal Complexes in Cancer Treatment: Journey So Far.
Kumar Singh A; Kumar A; Singh H; Sonawane P; Pathak P; Grishina M; Pal Yadav J; Verma A; Kumar P
Chem Biodivers; 2023 Apr; 20(4):e202300061. PubMed ID: 36824028
[TBL] [Abstract][Full Text] [Related]
18. Ruthenium(II) and Platinum(II) Complexes with Biologically Active Aminoflavone Ligands Exhibit In Vitro Anticancer Activity.
Fabijańska M; Kasprzak MM; Ochocki J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299199
[TBL] [Abstract][Full Text] [Related]
19. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
[TBL] [Abstract][Full Text] [Related]
20. Copper and Copper Complexes in Tumor Therapy.
Wang Y; Tang T; Yuan Y; Li N; Wang X; Guan J
ChemMedChem; 2024 Jun; 19(11):e202400060. PubMed ID: 38443744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]